参考文献/References:
[1]崔萍,于三科. 黏膜免疫佐剂及免疫途径研究进展[J]. 动物医学进展, 2007, 28(2):81-84.
[2]HUMPHRIES H E, WILLIAMS J N, CHRISTODOULIDES M, et al. Recombinant meningococcal PorA protein, expressed using a vector system with potential for human vaccination, induces a bactericidal immune response[J]. Vaccine, 2004, 22(11/12):1564-1569.
[3]BURKE J M, GANLEY-LEAL L M, KHATRI A, et al. Neisseria meningitidis PorB, a TLR2 ligand, induces an antigen-specific eosinophil recall response: potential adjuvant for helminth vaccines[J]. The Journal of Immunology, 2007, 179(5): 3222-3230.
[4]崔萍. 蛋白体黏膜佐剂的研究进展[J]. 中国微生态学杂志, 2013, 25(11):1353-1355.
[5]袁源,王栋,邢丽,等. 不同佐剂与鼠疫F1-V融合重组蛋白抗原滴鼻免疫效果的研究[J]. 免疫学杂志, 2009, 25(2):183-186.
[6]朱玲,郭万柱,徐志文. 猪伪狂犬病基因缺失活疫苗(SA215)免疫母猪后仔猪母源抗体消长规律及首免日龄[J]. 中国兽医学报, 2004, 24(4):320-322.
[7]郭广富,曹军平,朱爱萍,等.猪伪狂犬病病毒泰州株的分离鉴定[J].江苏农业科学,2015,43(3):200-202.
[8]贺卫洁. 猪瘟和猪伪狂犬病二联苗免疫干扰现象的研究[D]. 保定:河北农业大学, 2010.
[9]严琳. 猪白细胞介素2(pIL-2)与猪白细胞介素6(pIL-6)的基因表达及作为疫苗佐剂的研究[D]. 武汉:华中农业大学, 2005.
[10]张玲华,田兴山,邝哲师,等. CpG序列对猪伪狂犬疫苗免疫效果的影响[J]. 中国畜牧兽医, 2004, 31(3):37-39.
[11]赖庆光. 不同佐剂对伪狂犬活疫苗免疫效果的比较研究[D]. 南昌:江西农业大学, 2011.
[12]徐金生,吴时清,黄宝春,等. 应用微量中和试验检测进口奶牛血清中牛流行热病毒抗体[J]. 中国兽医科学, 1989(2):22-23.
[13]黄秋香,毕湖冰,张新文,等. Triton X-114液相分离法去除流感单价病毒原液中内毒素的实验研究[J]. 重庆医学, 2010, 39(4):385-387.
[14]STOKHOLM N M, PERMIN A, BISGAARD M, et al. Causes of mortality in commercial organic layers in Denmark[J]. Avian Diseases, 2010, 54(4):1241-1250.
[15]OGRA P L, FADEN H, WELLIVER R C. Vaccination strategies for mucosal immune responses[J]. Clinical Microbiology Reviews, 2001, 14(2):430-445.
[16]WRIGHT J C, WILLIAMS J N, CHRISTODOULIDES M, et al. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis[J]. Infection & Immunity, 2002, 70(8):4028-4034.
[17]PLATT A, MACLEOD H, MASSARI P, et al. In vivo and in vitro characterization of the immune stimulating activity of the Neisserial porin PorB[J]. Plos One, 2013, 8(12):e82171.
[18]CHIAVOLINI D, WEIR S, MURPHY J R, et al. Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia[J]. Clinical and Vaccine Immunology, 2008, 15(9): 1322-1329.
[19]ZHU W, THOMAS C E, SPARLING P F. DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment[J]. Vaccine, 2004, 22(5/6):660-669.
[20]PLANTE M, JONES T, ALLARD F, et al. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge[J]. Vaccine, 2001, 20(1/2):218-225.
[21]WILKE C M, WEI S, WANG L, et al. Dual biological effects of the cytokines interleukin-10 and interferon-γ[J]. Cancer Immunology, Immunotherapy, 2011, 60(11):1529-1541.
[22]MOORE K W, DE WAAL MALEFYT R, COFFMAN R L, et al. Interleukin-10 and the interleukin-10 receptor[J]. Annual Review of Immunology, 2001, 19(1): 683-765.
[23]MASSARI P, KING C A, MACLEOD H, et al. Improved purification of native meningococcal porin PorB and studies on its structure/function[J]. Protein Expression and Purification, 2005, 44(2): 136-146.
[24]SINGLETON T E, MASSARI P, WETZLER L M. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent[J]. Journal of Immunology, 2005, 174(6):3545-3550.
[25]李彦伸,戴建君,庾庆华. 黏膜免疫佐剂的研究进展[J]. 中国畜牧兽医, 2007, 34(12):86-90.